Trials / Completed
CompletedNCT01038869
Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)
Efficacy and Safety of Finacea in the Treatment of Post-Inflammatory Hyperpigmentation and Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Derm Research, PLLC · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Residual post-inflammatory hyperpigmentation (PIH)from acne is disturbing to individuals with skin of color. Finacea has been anecdotally known to be beneficial in resolving PIH related to acne vulgaris. However, it has not been clinically tested for this purpose. The current study will investigate the efficacy and safety of Finacea in the treatment of acne vulgaris and PIH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azelaic acid | Apply sparingly to the face twice a day (morning and night). Massage gently into the skin until vanishing. Approximately 0.5g (2.5cm strip) is sufficient for the entire facial area. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2009-12-24
- Last updated
- 2012-09-25
- Results posted
- 2012-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01038869. Inclusion in this directory is not an endorsement.